These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1149 related articles for article (PubMed ID: 25442913)
1. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents. Choukri F; Benderdouche M; Sednaoui P J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913 [TBL] [Abstract][Full Text] [Related]
2. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin]. Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765 [TBL] [Abstract][Full Text] [Related]
3. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.]. Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489 [TBL] [Abstract][Full Text] [Related]
4. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012. Liu XP; Fan SR; Peng YT; Zhang HP J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725 [TBL] [Abstract][Full Text] [Related]
5. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use]. Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253 [TBL] [Abstract][Full Text] [Related]
6. [Analysis of resistance and sensitivity of 1 200 strains of vulvovaginal candidiasis in China to five common antifungal drugs]. Fan LY; Liu ZH; Bai XN; Zong X Zhonghua Fu Chan Ke Za Zhi; 2022 Aug; 57(8):601-607. PubMed ID: 36008287 [No Abstract] [Full Text] [Related]
7. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis. Nagashima M; Yamagishi Y; Mikamo H J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336 [TBL] [Abstract][Full Text] [Related]
8. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis. Fan SR; Liu XP Mycoses; 2011 Nov; 54(6):501-5. PubMed ID: 20406393 [TBL] [Abstract][Full Text] [Related]
9. [Vulvovaginal candidiasis and sensitivity of pathogens to antimycotics]. Sojáková M; Liptajová D; Simoncicová M; Borovský M; Subík J Ceska Gynekol; 2003 Jan; 68(1):24-9. PubMed ID: 12708111 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina. Theill L; Dudiuk C; Morano S; Gamarra S; Nardin ME; Méndez E; Garcia-Effron G Rev Argent Microbiol; 2016; 48(1):43-9. PubMed ID: 26922471 [TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age. Khan F; Baqai R J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297 [TBL] [Abstract][Full Text] [Related]
13. Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China. Wang FJ; Zhang D; Liu ZH; Wu WX; Bai HH; Dong HY Chin Med J (Engl); 2016 May; 129(10):1161-5. PubMed ID: 27174323 [TBL] [Abstract][Full Text] [Related]
14. [In vitro susceptibility of vaginal isolates of Candida vs clotrimazole and nystatin]. Suárez VL; Fernández Andreu CM Rev Cubana Med Trop; 2003; 55(3):138-45. PubMed ID: 15849917 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates. Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724 [TBL] [Abstract][Full Text] [Related]
16. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. Richter SS; Galask RP; Messer SA; Hollis RJ; Diekema DJ; Pfaller MA J Clin Microbiol; 2005 May; 43(5):2155-62. PubMed ID: 15872235 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates. Brandolt TM; Klafke GB; Gonçalves CV; Bitencourt LR; Martinez AM; Mendes JF; Meireles MC; Xavier MO Braz J Microbiol; 2017; 48(1):145-150. PubMed ID: 27756539 [TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of oral Candida to seven antifungal agents. Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594 [TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006. Fan SR; Liu XP; Li JW J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710 [TBL] [Abstract][Full Text] [Related]
20. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam. Anh DN; Hung DN; Tien TV; Dinh VN; Son VT; Luong NV; Van NT; Quynh NTN; Van Tuan N; Tuan LQ; Bac ND; Luc NK; Anh LT; Trung DM BMC Infect Dis; 2021 Jun; 21(1):523. PubMed ID: 34082699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]